Yüksek Riskli Aort Darlığı Olan Hastalarda Transkateter Aortik Kapak İmplantasyonu Sonrası Vasküler Komplikasyonlar

Objective: This study aims to evaluate early results of our patients who underwent transluminal aortic valve implantation (TAVI). Material and Methods: Ninety-nine patients (59 females, 40 males; mean age 80.2±4.9 years; range 59 to 91 years) that had high surgical risk, and underwent TAVI procedure in our clinic between July 2012 and June 2015 were analyzed. All of our patients were implanted with Edwards Sapien bioprosthetic valves through transfemoral approach. Results: After both iliofemoral regions were covered in a sterile manner, TAVI process was performed usually (90.9%) in the right groin. Mortality due to a major vascular complication was not observed in any case. A hematoma not requiring any intervention developed in the femoral region of three (3.3%) cases. A superficial skin infection occurred in 2 (2.2%) cases in the incision of femoral region. Distal pulses could not be palpated in one case; but the case was followed medically after Doppler ultrasound. In one (1.1%) case, femoral arterial vasospasm developed during removal of the femoral arterial sheath Acute arterial obstruction developed in one(1.1%) case with severe calcification of femoral artery, and embolectomy was done. There was no femoral arterial flow in two cases (2.2%), and we performed embolectomy. In one (1.1%) case embolectomy + femoral arterial endarterectomy and safhenous patchplasty were done. One (1.1%) case was re-operated due to bleeding 4 hours after primary surgery. Plaque stabilization was carried out after removal of femoral arterial sheath in three (3.3%) cases. Conclusion: TAVI is a quite safe method in terms of procedural success in aortic stenosis patients with a high risk for open surgery. The early cardiovascular results following TAVI may be considered successful.